Blood Journals Portfolio/X
Jul 15, 2025, 07:37
Triple Therapy Breakthrough: Corticosteroids, IVIG, and Platelet Transfusions Transform Management of Critical ITP Bleeding – Blood Journals Portfolio
The Blood Journals Portfolio reported on its official X։
“The combination of corticosteroids, IV immunoglobulin, and platelet transfusion was the most common treatment for critical ITP bleeding.”
This recent report underscores the critical role of combination therapy—corticosteroids, IV immunoglobulin, and platelet transfusion—in effectively managing severe bleeding episodes in immune thrombocytopenia (ITP). It highlights the importance of timely, comprehensive treatment approaches to significantly improve patient outcomes in life-threatening situations.
For more detailed insights on this and other hemostasis topics, visit Hemostasis Today.
American Journal of Hematology
American Society of Hematology
American Thrombosis and Hemostasis Network
ASH
Bleeding management
Blood Journals Portfolio
Corticosteroids
Critical ITP Bleeding
Emergency hematology treatment
Hemostasis therapy
Hemostasis Today
Immune thrombocytopenia
Intravenous Immunoglobulin (IVIG)
ISTH
ITP Treatment
Platelet disorders
Platelet transfusion
Triple Therapy
-
Oct 21, 2025, 06:59Samwel Mikaye: Polycythemia and the Risk of Blood Clots
-
Oct 21, 2025, 06:58Samuel Nweke: Interpreting D-Dimer Results
-
Oct 21, 2025, 05:20Ewa Fiorentino Rozek: APS - When “Unprovoked” Clots And Pregnancy Loss Connect
-
Oct 21, 2025, 03:503 Questions With Abigail Ajanel Gomez – Touch Haematology Future Leader 2025
-
Oct 21, 2025, 01:57Mohamed Reda: Clotting Factors — The Key Players in Blood Coagulation
-
Oct 22, 2025, 10:35Evaluating a Novel Human Fibrinogen Concentrate (BT524) for Congenital Fibrinogen Deficiency
-
Oct 22, 2025, 09:37Jurjen Krommenhoek and Colleagues Propose a Clinical Care Pathway for Major Bleeding Survivors
-
Oct 22, 2025, 09:32Ishac Nazy: Proud Moment For Our Team!
-
Oct 22, 2025, 09:16Richard Benjamin Shares Results of The ReCePI Phase III Clinical Study
-
Oct 21, 2025, 11:13Hanny Al Samkari's Commentary on Iron Deficiency Anemia in Inherited Bleeding Disorders
-
Oct 22, 2025, 08:25Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
-
Oct 21, 2025, 06:58Arno Nierich: How Caffeine Affects Red Blood Cells and Blood Storage
-
Oct 21, 2025, 06:43Could Gene Therapy Offer Lasting Quality of Life for People with Hemophilia B?
-
Oct 21, 2025, 06:18Katerina Akassoglou Receives Zenith Fellows Award to Advance Alzheimer’s Research
-
Oct 16, 2025, 06:07ClearPlasma - A New Breakthrough in Stopping Life-Threatening Bleeds
-
Oct 22, 2025, 10:46Conversation with Ferran Nadeu – Touch Haematology Future Leader 2025
-
Oct 22, 2025, 10:32Lynn Malec - The New Director of the CCBD and Pharmacy at Children's Wisconsin
-
Oct 22, 2025, 09:41Deanna Joseph: Feeling Inspired and Deeply Grateful After Attending the 2025 HTRS SEARCH Workshop
-
Oct 22, 2025, 08:41Maryum Salim Reflects on Her Experience at the HTRS SEARCH Workshop
-
Oct 22, 2025, 08:36Emilya Huseynova to Speak at AABB 2025
Oct 22, 2025, 10:46
Oct 22, 2025, 10:32
Oct 22, 2025, 09:32
Oct 22, 2025, 09:16
Oct 22, 2025, 08:41
Oct 22, 2025, 08:36